| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PHAT
Phathom Pharmaceuticals
|
May 15, 2026 | BUY |
Strong Buy
+163.8% avg upside
14 analysts
|
$18.00
65.48% Upside
|
-8.3% |
|
TARS
Tarsus Pharmaceuticals
|
May 15, 2026 | BUY |
Strong Buy
+20.6% avg upside
16 analysts
|
$100.00
58.29% Upside
|
+2.1% |
|
PCRX
Pacira Pharmaceuticals
|
May 14, 2026 | HOLD |
Buy
+74.3% avg upside
21 analysts
|
$25.00
11.98% Upside
|
-3.8% |
|
XERS
Xeris Pharmaceuticals
|
May 13, 2026 | BUY |
Strong Buy
+33.6% avg upside
10 analysts
|
$9.00
29.43% Upside
|
+7.3% |
|
COLL
Collegium Pharmaceutical
|
May 12, 2026 | BUY |
Strong Buy
+25.7% avg upside
8 analysts
|
$56.00
66.98% Upside
|
-5.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.